Kalbe Farma Tbk PT : Disclosure of Information - Establishment of a Subsidiary, Kalbe Lanka (Pvt) Ltd.
October 28, 2019 at 04:32 am EDT
Share
In compliance with Indonesia Financial Services Authority Regulation No. 31/POJK.04/2015 dated December 16, 2015 regarding Disclosure of Information or Material Facts by the Issuer or a Listed Company, the Company hereby announces that :
a. Kalbe International Ltd ('KI') and PT Dankos Farma ('DF') are companies which their shares are 100% owned by the Company, both directly or indirectly;
b. On October 24, 2019, KI and DF agreed to establish a new company called Kalbe Lanka (Pvt) Ltd. the total paid up capital and issued capital is US$ 600,000 with a share of investment ownership of KI was US$ 594,000 (99%) and DF was US$ 6,000 (1%).
Attachments
Original document
Permalink
Disclaimer
PT Kalbe Farma Tbk published this content on 28 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 October 2019 08:31:06 UTC
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.